Impaired remyelination and depletion of oligodendrocyte progenitors does not occur following repeated episodes of focal demyelination in the rat central nervous system
Open accessThe DOI matches its Crossref record; 10 of the 10 references it cites were found in a registry or an index.
Abstract
It has been hypothesized that the progressive failure of remyelination in chronic multiple sclerosis is, in part, the consequence of repeated episodes of demyelination at the same site, eventually depleting oligodendrocyte progenitor cells (OPCs) and exhausting the remyelinating capacity. We investigated the effect of previous focal, ethidium bromide-induced demyelination of brain stem white matter (with intervening recovery) on the efficiency of the remyelination process during second and third subsequent episodes of demyelination, and the OPC response during a second episode of demyelination. Previous focal demyelinating lesions followed by recovery did not result in any retardation of the remyelination process, nor did they alter the proportion of Schwann cell versus oligodendrocyte remyelination. The OPC response during remyelination was quantified by in situ hybridization using a probe to platelet-derived growth factor-alpha receptor (PDGF alpha R), an OPC-expressed mRNA. Following recovery from focal, toxin-induced CNS demyelination, the OPC density returned to levels equivalent to those in normal white matter. Further more, there was no depletion of OPCs following repeated episodes of focal, toxin-induced CNS demyelination at the same site. These results indicate that repeated CNS demyelination, which has the opportunity to repair in the intervening period, is not characterized by impaired remyelination or depletion of OPCs.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
TNFα promotes proliferation of oligodendrocyte progenitors and remyelination
Arnett, H. A., Mason, J., Marino, M., Suzuki, K., Matsushima, G. K., & Ting, J. P.-Y. (2001) · Nature Neuroscience · doi:10.1038/nn738 · Cited by 1,012
Premyelinating Oligodendrocytes in Chronic Lesions of Multiple Sclerosis
Chang, A., Tourtellotte, W. W., Rudick, R., & Trapp, B. D. (2002) · New England Journal of Medicine · doi:10.1056/nejmoa010994 · Cited by 991 · cited 3×
“…signalling pathway (Wang et al., 1998; John et al., 2002) and PSA-NCAM (polysialylated neural cell adhesion molecule) (Charles et al., 2002), or due to changes in the properties of demyelinated axons that render them incapable of being remyelinated (Chang et al., 2002) is not fully resolved.”
BackgroundSim, F. J., Zhao, C., Penderis, J., & Franklin, R. J. M. (2002) · The Journal of Neuroscience · doi:10.1523/jneurosci.22-07-02451.2002 · Cited by 625
Self-citationMultiple sclerosis: Remyelination of nascent lesions: Remyelination of nascent lesions
Prineas, J. W., Barnard, R. O., Kwon, E. E., Sharer, L. R., & Cho, E. ‐. (1993) · Annals of Neurology · doi:10.1002/ana.410330203 · Cited by 574 · cited 3×
“Although remyelination occurs in many acute plaques of multiple sclerosis (Prineas and Connell, 1979; Prineas et al., 1993a; Lassmann et al., 1997), remyelination failure becomes an increasingly prominent feature of the pathology of chronic multiple sclerosis (Prineas et al., 2002).”
BackgroundWolswijk, G. (1998) · The Journal of Neuroscience · doi:10.1523/jneurosci.18-02-00601.1998 · Cited by 562
Interleukin-1β Promotes Repair of the CNS
Mason, J. L., Suzuki, K., Chaplin, D. D., & Matsushima, G. K. (2001) · The Journal of Neuroscience · doi:10.1523/jneurosci.21-18-07046.2001 · Cited by 502
Remyelination in multiple sclerosis
Prineas, J. W., & Connell, F. (1979) · Annals of Neurology · doi:10.1002/ana.410050105 · Cited by 454
Kotter, M. R., Setzu, A., Sim, F. J., Van Rooijen, N., & Franklin, R. J. M. (2001) · Glia · doi:10.1002/glia.1085 · Cited by 385 · cited 2×
“Depletion of macrophages or of key in ̄ammatory cytokines such as interleukin-1b and tumour necrosis factor-a results in an impairment of remyelination following toxininduced demyelination (Arnett et al., 2001; Kotter et al., 2001; Mason et al., 2001), while an impaired macrophage response in old animals compared with…”
BackgroundSelf-citationRemyelination in multiple sclerosis
Lassmann, H., Brück, W., Lucchinetti, C., & Rodriguez, M. (1997) · Multiple Sclerosis Journal · doi:10.1177/135245859700300213 · Cited by 191 · cited 1×
“Although remyelination occurs in many acute plaques of multiple sclerosis (Prineas and Connell, 1979; Prineas et al., 1993a; Lassmann et al., 1997), remyelination failure becomes an increasingly prominent feature of the pathology of chronic multiple sclerosis (Prineas et al., 2002).”
BackgroundArmstrong, R. C., Le, T. Q., Frost, E. E., Borke, R. C., & Vana, A. C. (2002) · The Journal of Neuroscience · doi:10.1523/jneurosci.22-19-08574.2002 · Cited by 178 · cited 2×
“…pro®le of secreted growth factors involved in remyelination by astrocytes , such as FGF or PDGF, may change without there being any histologically obvious change in their morphology (Redwine and Armstrong, 1998; Hinks and Franklin, 1999; Hinks and Franklin, 2000; Armstrong et al., 2002 ).”
Background
Cited by
Remyelination in the CNS: from biology to therapy
Franklin, R. J. M., & ffrench-Constant, C. (2008) · Nature Reviews Neuroscience · doi:10.1038/nrn2480 · Cited by 1,544
Self-citationPolydendrocytes (NG2 cells): multifunctional cells with lineage plasticity
Nishiyama, A., Komitova, M., Suzuki, R., & Zhu, X. (2009) · Nature Reviews Neuroscience · doi:10.1038/nrn2495 · Cited by 865
“Furthermore, demyelinated lesions repeatedly created in the cerebellar peduncle by injecting ethidium bromide at 8-week intervals were fully remyelinate”
BackgroundKuhlmann, T., Miron, V., Cuo, Q., Wegner, C., Antel, J., & Bruck, W. (2008) · Brain · doi:10.1093/brain/awn096 · Cited by 864
Regenerating CNS myelin — from mechanisms to experimental medicines
Franklin, R. J. M., & ffrench-Constant, C. (2017) · Nature Reviews Neuroscience · doi:10.1038/nrn.2017.136 · Cited by 647
Self-citationThe cuprizone animal model: new insights into an old story
Kipp, M., Clarner, T., Dang, J., Copray, S., & Beyer, C. (2009) · Acta Neuropathologica · doi:10.1007/s00401-009-0591-3 · Cited by 481
“Therefore, remyelination seems not to be limited by an absence of OPC or their failure to generate oligodendrocytes [18, 78].”
BackgroundRemyelination capacity of the MS brain decreases with disease chronicity
Goldschmidt, T., Antel, J., König, F. B., Brück, W., & Kuhlmann, T. (2009) · Neurology · doi:10.1212/wnl.0b013e3181a8260a · Cited by 411
Fancy, S. P. J., Zhao, C., & Franklin, R. J. M. (2004) · Molecular and Cellular Neuroscience · doi:10.1016/j.mcn.2004.06.015 · Cited by 302
Self-citationRemyelination in Experimental Models of Toxin-Induced Demyelination
Blakemore, W. F., & Franklin, R. J. M. (2008) · Current Topics in Microbiology and Immunology · doi:10.1007/978-3-540-73677-6_8 · Cited by 275
“remyelination in lesions made at this site is considerably less than in spinal cord lesions and even in old animals constitutes less than 15% of total remyelination (Fig. 3). Ethidium bromide lesions in the cervical spinal cord of rats have been used for functional studies [51], while the CCP lesion has been used in r…”
MethodSelf-citationMason, J. L., Toews, A., Hostettler, J. D., Morell, P., Suzuki, K., Goldman, J. E., & Matsushima, G. K. (2004) · The American Journal of Pathology · doi:10.1016/s0002-9440(10)63726-1 · Cited by 212
CNS remyelination and inflammation: From basic mechanisms to therapeutic opportunities
Franklin, R. J. M., & Simons, M. (2022) · Neuron · doi:10.1016/j.neuron.2022.09.023 · Cited by 184
Self-citationThe translational biology of remyelination: past, present, and future
Franklin, R. J. M., & Gallo, V. (2014) · Glia · doi:10.1002/glia.22622 · Cited by 162
Self-citationStidworthy, M. F. (2004) · Brain · doi:10.1093/brain/awh217 · Cited by 158
“To study the role of the Notch–Jagged pathway in remyelination we have examined the expression of Notch and Jagged in an experimental model of demyelination that undergoes complete remyelination (Woodruff and Franklin, 1999; Penderis et al., 2003).”
BackgroundMurtie, J. C., Zhou, Y.-X., Le, T. Q., Vana, A. C., & Armstrong, R. C. (2005) · Neurobiology of Disease · doi:10.1016/j.nbd.2004.12.006 · Cited by 157
Dulamea, A. O. (2017) · Advances in Experimental Medicine and Biology · doi:10.1007/978-3-319-47861-6_7 · Cited by 128
Stem cells, progenitors and myelin repair
Zhao, C., Fancy, S. P. J., Magy, L., Urwin, J. E., & Franklin, R. J. M. (2005) · Journal of Anatomy · doi:10.1111/j.1469-7580.2005.00456.x · Cited by 61
“When the same area of CNS is exposed to several rounds of demyelination/remyelination, the OPC numbers are not reduced and the efficiency of remyelination is not impaired by previous rounds of remyelination (Penderis et al. 2003).”
Self-citationZhao, C., Fancy, S. P. J., ffrench-Constant, C., & Franklin, R. J. M. (2008) · Neurobiology of Disease · doi:10.1016/j.nbd.2008.04.007 · Cited by 47
Self-citationRodriguez, E. G., Wegner, C., Kreutzfeldt, M., Neid, K., Thal, D. R., Jürgens, T., Brück, W., Stadelmann, C., & Merkler, D. (2014) · Acta Neuropathologica · doi:10.1007/s00401-014-1260-8 · Cited by 44
“efficient remyelination was observed after three repeated injections of ethidium bromide into the cerebellar peduncle [40].”
BackgroundRemyelination in the central nervous system
Franklin, R. J. M., Bodini, B., & Goldman, S. A. (2024) · Cold Spring Harbor Perspectives in Biology · doi:10.1101/cshperspect.a041371 · Cited by 40
Self-citationRemyelinating and neuroprotective treatments in multiple sclerosis
Stangel, M. (2004) · Expert Opinion on Investigational Drugs · doi:10.1517/13543784.13.4.331 · Cited by 22
Remyelination in animal models of multiple sclerosis: finding the elusive grail of regeneration
Packer, D., Fresenko, E. E., & Harrington, E. P. (2023) · Frontiers in Molecular Neuroscience · doi:10.3389/fnmol.2023.1207007 · Cited by 21
Metadata
- Authors
- Penderis, J., Shields, S. A., & Franklin, R. J. M.
- Venue
- Brain
- Publisher
- Oxford University Press (OUP)
- Published
- 2003-06
- Volume
- 126
- Issue
- 6
- Pages
- 1382-1391
- ISSN
- 0006-8950 (ISSN-L)
- 1460-2156
- OpenAlex
- W2122417496
- Cited by
- 129
- References
- 10
- FWCI
- 4.78
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.